Hospital-acquired pneumonia

Introduction

Hospital-acquired Pneumonia (HAP), also known as nosocomial pneumonia, is a type of pneumonia that patients contract during their stay in a hospital, typically manifesting at least 48-72 hours after admission. This distinguishes it from community-acquired pneumonia, which is contracted outside of a hospital setting.

A hospital room, where patients might be at risk of contracting HAP.

Etiology and Pathogenesis

HAP predominantly arises from bacterial infections, as opposed to viral sources. The bacteria responsible can often be multi-drug resistant, making treatment challenging.

Common Causative Agents

• Staphylococcus aureus: Especially the methicillin-resistant strain (MRSA).
• Pseudomonas aeruginosa
• Klebsiella pneumoniae
• Escherichia coli

Prevalence and Impact

HAP stands as the second most prevalent nosocomial infection, trailing only urinary tract infections in frequency. It constitutes 15-20% of all hospital-acquired infections. Its significance is further underscored by the following:

• It ranks as the leading cause of death from hospital-acquired infections.
• Among all ICU fatalities, HAP is the foremost cause.
• Patients diagnosed with HAP generally experience a prolongation of their hospital stay by an additional 1-2 weeks, leading to increased medical costs and resource utilization.

An X-ray showing a case of pneumonia.

Diagnosis and Treatment

Early diagnosis and prompt treatment are crucial to improving patient outcomes. Diagnostic measures include:

• Clinical assessment: Observing symptoms like fever, cough, and increased sputum production.
• Radiological findings: Chest X-rays or CT scans showcasing lung infiltrates.
• Microbiological tests: Sputum cultures to identify the causative agent.

Treatment primarily hinges on antibiotic therapy, tailored to the identified bacteria and its antibiotic resistance pattern. Preventive measures, such as proper hand hygiene practices and respiratory care protocols, play a pivotal role in minimizing the risk of HAP.

Conclusion

Hospital-acquired Pneumonia remains a significant concern in healthcare settings, especially for patients in intensive care units. Awareness, early detection, and adherence to preventive guidelines are imperative to mitigate its incidence and associated morbidity and mortality.